methenamine 162 MG / sodium salicylate 162.5 MG Oral Tablet [Cystex]
RxNorm concept 1489934, branded drug (sbd). Prescribable name: CYSTEX PLUS 162 MG / 162.5 MG Oral Tablet.
- RxCUI
- 1489934
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1489934 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Cystex (methenamine 162 MG / sodium salicylate 162.5 MG) Oral Tablet
Related concepts
- methenamine 162 MG (SCDC, consists of)
- sodium salicylate 162.5 MG (SCDC, consists of)
- methenamine 162 MG / sodium salicylate 162.5 MG [Cystex] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Cystex (BN, has ingredient)
- methenamine 162 MG / sodium salicylate 162.5 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 69693051220
- 69693051224
- 69693051240
- 69693051248
- 69693051324
- 69693051348
- 69693051824
- 69693051848
- 89476051240
- 89476051248
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1489934 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1489934 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1489934. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.